ES2531093T3 - Procedimiento de preparación de halogenuros de N-alquil-naltrexona - Google Patents

Procedimiento de preparación de halogenuros de N-alquil-naltrexona Download PDF

Info

Publication number
ES2531093T3
ES2531093T3 ES07848250T ES07848250T ES2531093T3 ES 2531093 T3 ES2531093 T3 ES 2531093T3 ES 07848250 T ES07848250 T ES 07848250T ES 07848250 T ES07848250 T ES 07848250T ES 2531093 T3 ES2531093 T3 ES 2531093T3
Authority
ES
Spain
Prior art keywords
naltrexone
halides
alkyl
preparation procedure
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07848250T
Other languages
English (en)
Inventor
Alain Dlubala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2531093T3 publication Critical patent/ES2531093T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Ion doble de N-metil-naltrexona, de la fórmula:**Fórmula** en forma de anhidro o de hidrato.
ES07848250T 2006-09-21 2007-09-19 Procedimiento de preparación de halogenuros de N-alquil-naltrexona Active ES2531093T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0608286A FR2906252B1 (fr) 2006-09-21 2006-09-21 Procede de preparation d'halogenures de n-aklyl naltrexone
PCT/FR2007/001516 WO2008034973A1 (fr) 2006-09-21 2007-09-19 Procede de preparation d'halogenures de n-alkyl naltrexone

Publications (1)

Publication Number Publication Date
ES2531093T3 true ES2531093T3 (es) 2015-03-10

Family

ID=38016779

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07848250T Active ES2531093T3 (es) 2006-09-21 2007-09-19 Procedimiento de preparación de halogenuros de N-alquil-naltrexona

Country Status (35)

Country Link
US (2) US7645880B2 (es)
EP (1) EP2069362B1 (es)
JP (1) JP5214615B2 (es)
KR (1) KR101434693B1 (es)
CN (2) CN102225939A (es)
AR (1) AR062918A1 (es)
AU (1) AU2007298855B2 (es)
BR (1) BRPI0718440A2 (es)
CA (1) CA2663509C (es)
CL (1) CL2007002711A1 (es)
CO (1) CO6170362A2 (es)
CR (1) CR10660A (es)
DO (1) DOP2011000307A (es)
EA (1) EA015426B1 (es)
ES (1) ES2531093T3 (es)
FR (1) FR2906252B1 (es)
GT (1) GT200900060A (es)
HN (1) HN2009000503A (es)
IL (1) IL197402A (es)
JO (1) JO3023B1 (es)
MA (1) MA30793B1 (es)
ME (1) MEP10509A (es)
MX (1) MX2009003084A (es)
MY (1) MY148094A (es)
NI (1) NI200900035A (es)
NO (1) NO20091561L (es)
NZ (1) NZ575417A (es)
PE (1) PE20080867A1 (es)
SV (1) SV2009003192A (es)
TN (1) TN2009000080A1 (es)
TW (1) TWI465451B (es)
UA (1) UA96957C2 (es)
UY (1) UY30599A1 (es)
WO (1) WO2008034973A1 (es)
ZA (1) ZA200901846B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009010550A (es) 2007-03-29 2009-12-14 Progenics Pharm Inc Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
WO2008138383A1 (de) * 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
US8383649B2 (en) * 2007-07-11 2013-02-26 Mallinckrodt Llc Crystalline forms of naltrexone methobromide
EP2019105A1 (en) * 2007-07-19 2009-01-28 Siegfried Ltd. Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives
WO2010039209A2 (en) * 2008-09-30 2010-04-08 Mallinckrodt Inc. Processes for the synthesis of tertiary amines
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
EP2398807A1 (en) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
CN102325777B (zh) * 2009-02-23 2015-08-12 马林克罗特公司 (+)-吗啡喃*n-氧化物及其制备方法
US8436174B2 (en) * 2009-02-23 2013-05-07 Mallinckrodt Llc (+)-morphinanium quaternary salts and processes for their production
KR20120088537A (ko) 2009-04-24 2012-08-08 브럭 유니버시티 모르피난 및 모르피논 화합물의 제조방법
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
CN101845047B (zh) * 2009-12-31 2011-12-07 南京臣功制药有限公司 一种溴甲基纳曲酮的制备方法
RS55777B1 (sr) 2010-11-05 2017-07-31 H Lundbeck As Postupak za proizvodnju naltreksona
JO3209B1 (ar) * 2010-11-05 2018-03-08 H Lundbeck As طريقة لتصنيع نالتريكسون
US8580963B2 (en) 2010-11-05 2013-11-12 H. Lundbeck A/S Method for the manufacturing of naltrexone
WO2012138888A1 (en) 2011-04-05 2012-10-11 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
CN103917543A (zh) 2011-09-08 2014-07-09 马林克罗特有限公司 在不分离中间体的情况下制备生物碱
CN103172640A (zh) * 2011-12-22 2013-06-26 天津康鸿医药科技发展有限公司 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物
US20140155608A1 (en) 2012-05-03 2014-06-05 H. Lundbeck A/S Method for the manufacturing of naltrexone
CN105985348B (zh) * 2015-02-12 2019-02-01 正大天晴药业集团股份有限公司 一种溴甲基纳曲酮的制备方法
CN106317064B (zh) * 2015-06-30 2018-06-19 北大方正集团有限公司 溴甲纳曲酮的制备方法
KR102201609B1 (ko) * 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
CN111777617B (zh) * 2020-07-10 2025-06-06 华润三九医药股份有限公司 一种溴甲纳曲酮的精制方法
WO2022076470A1 (en) 2020-10-06 2022-04-14 Sorrento Therapeutics, Inc. Oral delayed burst formulation of low-dose naltrexone or naloxone used for|treating fibromyalgia and long covid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
ATE444295T1 (de) * 2002-11-08 2009-10-15 Mallinckrodt Inc Verfahren zur herstellung von quaternäre n-alkyl morphinan alkaloid salzen
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
EP2069362A1 (fr) 2009-06-17
SV2009003192A (es) 2009-10-27
US7645880B2 (en) 2010-01-12
CR10660A (es) 2009-06-24
CA2663509C (fr) 2014-03-18
PE20080867A1 (es) 2008-08-22
ME00613B (me) 2011-12-20
JP5214615B2 (ja) 2013-06-19
IL197402A (en) 2012-12-31
NO20091561L (no) 2009-06-16
MX2009003084A (es) 2009-04-02
WO2008034973A1 (fr) 2008-03-27
NZ575417A (en) 2011-09-30
KR101434693B1 (ko) 2014-08-27
MY148094A (en) 2013-02-28
US20080214817A1 (en) 2008-09-04
FR2906252B1 (fr) 2008-11-28
TWI465451B (zh) 2014-12-21
TW200821314A (en) 2008-05-16
UA96957C2 (ru) 2011-12-26
EA200970307A1 (ru) 2009-12-30
US20100145051A1 (en) 2010-06-10
TN2009000080A1 (en) 2010-08-19
AU2007298855B2 (en) 2012-09-13
ZA200901846B (en) 2010-07-28
MA30793B1 (fr) 2009-10-01
BRPI0718440A2 (pt) 2013-11-19
GT200900060A (es) 2011-01-04
AR062918A1 (es) 2008-12-17
KR20090057031A (ko) 2009-06-03
AU2007298855A1 (en) 2008-03-27
US8288547B2 (en) 2012-10-16
HN2009000503A (es) 2011-03-02
DOP2011000307A (es) 2011-10-31
IL197402A0 (en) 2009-12-24
CL2007002711A1 (es) 2008-04-18
CA2663509A1 (fr) 2008-03-27
JP2010504308A (ja) 2010-02-12
EP2069362B1 (fr) 2014-07-09
JO3023B1 (ar) 2016-09-05
UY30599A1 (es) 2008-05-02
MEP10509A (en) 2011-12-20
CN101516892A (zh) 2009-08-26
FR2906252A1 (fr) 2008-03-28
CO6170362A2 (es) 2010-06-18
CN102225939A (zh) 2011-10-26
NI200900035A (es) 2010-01-26
CN101516892B (zh) 2012-06-20
HK1135389A1 (en) 2010-06-04
EA015426B1 (ru) 2011-08-30

Similar Documents

Publication Publication Date Title
ES2531093T3 (es) Procedimiento de preparación de halogenuros de N-alquil-naltrexona
CY1122330T1 (el) Συνθεσεις δισκιων μηλεϊνικης νερατινιμπης
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
UA107791C2 (en) Pesticidal compositions
SMT201600475T1 (it) Procedimenti per la preparazione di inibitori di sglt2.
EA201071032A1 (ru) Гетероциклическое соединение
BRPI0907563A2 (pt) Derivados de 4,5-di-hidro-xazol-2-il amina
WO2010014836A3 (en) Tgr5 modulators and methods of use thereof
MY153915A (en) Organic compounds
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
TN2011000293A1 (en) Protein kinase inhibitors
BRPI0918472A2 (pt) composto 2,4-diaminopirimidina
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
EA201290642A1 (ru) Соединения и способы
TNSN08191A1 (en) Kinase inhibitors
BRPI0923048A2 (pt) "composto de aminopirazol".
BRPI0922280A2 (pt) "métodos para preparo de aerogéis híbridos".
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
CO6382123A2 (es) Antagonistas de la via hedgehog de ftalazina disustituida
BRPI0720050A2 (pt) 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas
UY29857A1 (es) Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica.
TW200700064A (en) Novel compounds
IL208637A (en) 2, 6 - Diamino-pyrimidine-5-yl-carboxyamides as inhibitors of syc or jak kinases
UA104420C2 (uk) Застосування похідних глутарової кислоти або їх фармацевтично прийнятних солей як протиаритмічних засобів